The University of Arizona received a $1.1 million grant to study the biology underlying the connection between type 2 diabetes and cardiovascular disease.
The UA’s Dr. Yann Klimentidis said an end goal for this type of research is to learn more about individuals.
“So, being able to say based on your genetic profile, based on your DNA sequence looks like you are at very high risk at heart disease or based on your genetic profile you are at high risk of developing Type 2 diabetes if you take statins,” said Dr. Klimentidis as a way of understanding why this happens to improve outcomes for patients.
The study will utilize publicly available health and genetic information from databases across the world, covering at least 650,000 people. The research could also produce knowledge to help prescribe drugs based on a person’s genetics.
